top of page
Gotham__Org Gotham White.png

Functional Assessment of Cancer Therapy – General – 7 Item Version

Can be used with patients of any tumor type



The Functional Assessment of Cancer Therapy – General – 7 Item Version (FACT-G7) is a shortened, 7-item version of the FACT-G designed to quickly and effectively capture the most relevant issues to cancer patients in a valid and reliable manner. Development included oncology patients with advanced cancer from 11 disease sites who ranked the symptoms and concerns they viewed as ‘the very most important’ when undergoing cancer treatment and completed the FACT-G. Of the highest priority cancer-related symptoms and concerns endorsed by patients for inclusion in the FACT-G7, fatigue and ability to enjoy life were ranked the most highly. The FACT-G7 can be used to rapidly assess top-rated symptoms and concerns for a broad spectrum of advanced cancers in clinical practice and research, as well as for quality reporting in cancer chemotherapy and radiation.


Functional Assessment of Cancer Therapy – General – 7 Item Version (FACT-G7)






Cancer patients 18 years and older


Past 7 days


5 point Likert-type scale


Paper and electronic


Self-administration and interview when applicable


Physical well-being, Emotional Well-Being, Functional Well-Being


less than 5 minutes


Manual scoring template, some items are reverse scored. Total scores possible.


Language Availability

Available translations of the FACT-G7 can be obtained by registering for permission. Users are not permitted to translate the FACT-G7 without permission from Permission from to translate the FACT-G7 may also be contingent upon timeline expectations and availability of FACIT staff. Translations must undergo a rigorous methodology under the guidance of which includes multiple translators, QA steps and cognitive interviews with patients. For commercial use, FACITtrans is the approved translation vendor to translate the FACIT measurement system.

Please contact us for more information.

Language Availability


Licensing fees are assessed on a per trial/per measure basis for commercial use. There is no fee for use of the English version, but a license should be obtained. ​

Non-commercial use is assessed on a case-by-case basis. Licensing fees are typically not applied to investigator-initiated research, students, or clinical use.

To license an available version of this measure for commercial or non-commercial use, please complete our registration form. All of the information provided in the form will be kept strictly confidential. For questions, please contact us.

Selected References

Selected References

King, M., Agar, M., Currow, D., Hardy, J., Fazekas, B., & McCaffre, N. Assessing quality of life in palliative care settings: head-to-head comparison of four patient-reported outcome measures (EORTC QLQ-C15-PAL, FACT-Pal, FACT-Pal-14, FACT-G7). Supportive Care in Cancer 2020; 28:141–153. doi: 10.1007/s00520-019-04754-9.

Yanez B., Pearman T., Lis C.G., Beaumont J.L., Cella D. The FACT-G7: A rapid version of the Functional Assessment of Cancer Therapy – General (FACT-G) for monitoring symptoms and concerns in oncology practice and research. Annals of Oncology 2013; 24: 1073-1078. doi:10.1093/annonc/mds539.

Bonomi, A.E., Cella, D.D., Hahn, E.A., Bjordal, K., Sperner, B., Gangeri, L., Bergman, B., Willems, J., Hanquet, P., & Zittoun, R. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Quality of Life Research 1996; 5: 309-320.

Eremenco, S., Arnold, B., Cella, D. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Evaluation & the Health Professions 2005; 28(2): 212-232.

Pearman,T., Yanez B., Peipert, J., Wortman K., Beaumont J., & Cella D. Ambulatory cancer and US general population reference values and cutoff scores for the Functional Assessment of Cancer Therapy. Cancer 2014: 2902-2909. doi: 10.1002/cncr.28758.

Webster, K., Cella, D., & Yost, K. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties applications, and interpretation. Health and Quality of Life Outcomes 2003; 1(1): 79-85.

Yost K.J., Eton D.T. Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Evaluation & the Health Professions2005; 28(2): 172-191.

Related Measures

Related Measures


Functional Assessment of Cancer Therapy - General


Functional Assessment of Cancer Therapy - General Population


Functional Assessment of Non-Life Threatening Conditions

bottom of page